The two treatments could ‘constitute an early stage and late stage treatment option for all COVID-19 patients’

The research hub includes a biomedical database, scientific and clinical content, COVID-19-specific datasets, and more

Almac and MSD will initially work together in a two-year joint research programme

The test will identify if a person has had the novel COVID-19 virus